The Effect of Sujok Therapy on Cancer Symptoms

Not Applicable

Completed

• Conditions: Cancer

• Registration Number: NCT05265754
• Lead Sponsor: Ataturk University

Brief Summary

The aim of this study is to determine the effect of Sujok therapy on Pain, Fatigue, Insomnia, Nausea and Vomiting experienced by patients with gastrointestinal system cancer.

Detailed Description

The aim of this study is to determine the effect of Sujok treatment on Pain, Fatigue, Insomnia, Nausea and Vomiting experienced by patients with gastrointestinal system cancer. Intervention and control groups will be determined by randomization. The scales to be used in the measurement will be applied to the individuals included in the study. Then, sujok therapy will be applied to the intervention group. After 6 sessions in weeks in total, measurement tools will be applied and evaluated again.

Study Timeline

• Study Start: 2022-02-01
• Study First Submitted: 2022-02-04
• Study First Submitted QC: 2022-02-22
• Study First Posted: 2022-03-04
• Primary Completion: 2022-06-01
• Study Completion: 2022-09-05
• Status Verified: 2023-02
• Last Update Submitted: 2023-02-22
• Last Update Posted: 2023-02-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 49

Inclusion Criteria

• over 18 years old
• Fatigue Severity Measurement - Visual Analogue Scale (VAS) fatigue score of 3 and above,
• Pain Severity Measurement - Visual Analogue Scale (VAS) pain score of 3 and above,
• Measurement of Nausea and Vomiting Severity - Patients with a Visual Analogue Scale (VAS) nausea and vomiting score of 3 and above will be included.

Exclusion Criteria

• Loss of sensation, amputation, injury, colostomy, etc., which will prevent practice in hands. patients will be excluded from the study.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Sujok Therapy's positive change in Fatigue Experienced by Patients with Gastrointestinal System Cancer	2 weeks	To assess the fatigue, the cancer fatigue scale will be applied before starting the sujok application and after the sujok applied for 2 weeks.
Sujok Therapy's positive cahange in nausea and vomiting Experienced by Patients with Gastrointestinal System Cancer	2 weeks	To evaluate nausea and vomiting, the Rhodes nausea vomiting scale will be applied before starting the sujok application and after the sujok applied for 2 weeks
Sujok Therapy's positive cahange in insomnia Experienced by Patients with Gastrointestinal System Cancer	2 weeks	In order to evaluate insomnia,the insomnia severity index will be applied before starting the sujok application and after the sujok applied for 2 weeks
Sujok Therapy's Positive Change in Pain Experienced by Gastrointestinal System Cancer Patients	2 weeks	To assess the pain, the MCgill Pain Scale will be applied before starting the sujok application and after the sujok applied for 2 weeks.

Trial Locations

Locations (1)

Atatürk Universty; 🇹🇷 Erzurum, Turkey